Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Down - What's Next?

Key Points

• AAPG shares fell 4.5%, opening at $14.23 after previously closing at $14.88, and last traded at $14.07 on very light volume.
• Analysts remain broadly bullish, with a consensus “Buy” rating and a $43.90 average price target, although JPMorgan recently cut its target from $46 to $33.
• The company reported a quarterly loss of $0.65 per share on $22.24 million in revenue, while analysts expect a full-year loss of approximately $2.43 per share.

Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) shares gapped down before the market opened on Monday. The stock had previously closed at $14.88, but opened at $14.23. Ascentage Pharma Group International shares last traded at $14.07, with a volume of 429 shares.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the company. JPMorgan Chase & Co. reduced their target price on Ascentage Pharma Group International from $46.00 to $33.00 and set an "overweight" rating for the company in a report on Thursday, October 8th. BTIG Research restated a "buy" rating and issued a $48.00 price objective on shares of Ascentage Pharma Group International in a research note on Friday, August 21st. Citizens Jmp began coverage on shares of Ascentage Pharma Group International in a report on Tuesday, October 13th. They set a "market outperform" rating and a $35.00 price objective for the company. Citigroup assumed coverage on shares of Ascentage Pharma Group International in a report on Wednesday, October 14th. They issued a "buy" rating and a $46.00 target price on the stock. Finally, William Blair began coverage on Ascentage Pharma Group International in a research report on Friday, October 16th. They issued an "outperform" rating on the stock. Two research analysts have rated the stock with a Strong Buy rating and twelve have assigned a Buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Buy" and a consensus target price of $43.90.

Ascentage Pharma Group International Trading Down 4.5%

The stock's 50 day moving average is $15.85 and its two-hundred day moving average is $20.20. The company has a debt-to-equity ratio of 1.09, a current ratio of 1.22 and a quick ratio of 1.18.

Ascentage Pharma Group International (NASDAQ:AAPG - Get Free Report) last announced its earnings results on Wednesday, August 19th. The company reported ($0.65) earnings per share (EPS) for the quarter. The company had revenue of $22.24 million for the quarter. As a group, research analysts anticipate that Ascentage Pharma Group International - Unsponsored ADR will post -2.43 earnings per share for the current fiscal year.

Ascentage Pharma Group International Company Profile

Ascentage Pharma Group International is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for cancer and other serious diseases.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.